Sourcing Turkish Natural Cosmetic Ingredients for the USA

The United States is one of the largest and most dynamic markets for natural personal care, driven by a deep bench of indie and clean-beauty brands that compete on authenticity. Turkey sits well with that demand — but selling into the US is not the same as selling into Europe. The regulator is different, the trade relationship is different, and since 2022 the rulebook itself has changed. This guide sets out what a US buyer and a Turkish supplier need to get right.

Why US clean-beauty brands look to Turkey

American formulators increasingly want ingredients with a verifiable origin and a genuine story, and Turkish naturals deliver both. Rosa damascena rose oil and rose water from the Isparta region are benchmark materials that a synthetic or blended alternative cannot replicate. Oregano oil, along with a wide range of aromatic and medicinal herbs and botanical extracts, rounds out a supply base built on long-established cultivation and distillation. For an indie brand differentiating on provenance, single-origin Turkish lots with full traceability are a marketing and a quality asset at once. The scale of the US natural personal-care segment also means a supplier can grow with a customer, from a small artisan run to a national retail launch, without changing origin.

How MoCRA changed the rules

For years, US cosmetics law was famously light-touch. The Modernization of Cosmetics Regulation Act (MoCRA), enacted in 2022, changed that. It introduced facility registration, product listing with the FDA, a designated Responsible Person, safety substantiation and adverse-event reporting. Crucially for exporters, the burden of proving safety now sits squarely with the brand placing the product on the market. That flows straight back down the supply chain: US customers ask their Turkish suppliers for more, and better, documentation than before, because they cannot substantiate what they cannot document.

FDA labelling versus the EU

It is tempting to treat US and EU requirements as interchangeable, but they diverge in important ways. There is generally no pre-market approval for most cosmetics in the US — the FDA does not clear a product before sale — yet the product must still be safe and correctly labelled. Both markets use INCI nomenclature, so ingredient names travel well, but the surrounding label follows FDA rather than EU conventions: the EU allergen-declaration list does not apply in the same form, and format details differ. Colour additives are a notable exception, carrying specific FDA listing and, in some cases, certification rules. The safe course is to build US-specific label artwork rather than reuse European labels.

Duties, customs and FDA import screening

Turkey has no EU-style customs union with the United States, so goods do not move duty-free. US import duties and tariffs apply, and shipments clear through US Customs and Border Protection alongside FDA import screening, which can hold or examine cosmetic consignments. Rates and procedures depend on the specific material and current trade policy, so a US buyer should confirm classification and landed cost with a customs broker rather than assume parity with an EU shipment. Complete, consistent paperwork is the single biggest factor in a clean, fast release at the border. Mismatched product descriptions, missing safety data or an unclear intended use are common reasons a natural-ingredient shipment is delayed, so aligning the commercial invoice, the CoA and the label story before goods leave Turkey pays for itself.

Documentation a US buyer expects

A well-prepared documentation pack is now table stakes. For each material, a US customer will typically want:

MoCRA has raised these expectations across the whole supply chain, because the Responsible Person can only substantiate safety with real data behind it. A Turkish supplier that provides this pack as a matter of routine removes friction, shortens qualification and makes itself the easy choice for a US brand that has to answer to the FDA.